Exact Mass: 719.324

Exact Mass Matches: 719.324

Found 10 metabolites which its exact mass value is equals to given mass value 719.324, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

   
   

(6E,8E,10E,16Z)-15,28-Dihydroxy-5-methoxy-14,16-dimethyl-3,24-dioxo-22-thia-2,25-diazatricyclo[18.7.1.0(21,26)]octacosa-1(28),6,8,10,16,20,26-heptaen-13-yl 1-[(1-cyclohexen-1-ylcarbonyl)amino]cyclopropanecarboxylate

(6E,8E,10E,16Z)-15,28-Dihydroxy-5-methoxy-14,16-dimethyl-3,24-dioxo-22-thia-2,25-diazatricyclo[18.7.1.0(21,26)]octacosa-1(28),6,8,10,16,20,26-heptaen-13-yl 1-[(1-cyclohexen-1-ylcarbonyl)amino]cyclopropanecarboxylate

C39H49N3O8S (719.324)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins

   

(4Z,10E,12E,14E)-6,28-Dihydroxy-16-methoxy-5,7-dimethyl-18,24-dioxo-22-thia-19,25-diazatricyclo[18.7.1.0(21,26)]octacosa-1(28),4,10,12,14,20,26-heptaen-8-yl 1-[(1-cyclohexen-1-ylcarbonyl)amino]cyclopropanecarboxylate

(4Z,10E,12E,14E)-6,28-Dihydroxy-16-methoxy-5,7-dimethyl-18,24-dioxo-22-thia-19,25-diazatricyclo[18.7.1.0(21,26)]octacosa-1(28),4,10,12,14,20,26-heptaen-8-yl 1-[(1-cyclohexen-1-ylcarbonyl)amino]cyclopropanecarboxylate

C39H49N3O8S (719.324)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins

   

TMC-135B

TMC-135B

C39H49N3O8S (719.324)


An organonitrogen heterocyclic compound that is a 21-membered macrocyclic lactam substituted by a ({1-[(cyclohex-1-en-1-ylcarbonyl)amino]cyclopropyl}carbonyl)oxy group at position 18. It is isolated from Streptomyces sp. TC-1190 and exhibits growth inhibitory effects on a series of human tumour cell lines.

   

TMC-135A

TMC-135A

C39H49N3O8S (719.324)


An organonitrogen heterocyclic compound that is a 21-membered macrocyclic lactam, substituted by a ({1-[(cyclohex-1-en-1-ylcarbonyl)amino]cyclopropyl}carbonyl)oxy group at position 17, which is obtained from Streptomyces sp. TC-1190. It exhibits growth inhibitory effects on a series of human tumour cell lines.

   

n-{1-[({3,15,24,28-tetrahydroxy-5-methoxy-14,16-dimethyl-22-thia-2,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),2,6,8,10,16,20(28),21(26),24-nonaen-13-yl}oxy)carbonyl]cyclopropyl}cyclohex-1-ene-1-carboximidic acid

n-{1-[({3,15,24,28-tetrahydroxy-5-methoxy-14,16-dimethyl-22-thia-2,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),2,6,8,10,16,20(28),21(26),24-nonaen-13-yl}oxy)carbonyl]cyclopropyl}cyclohex-1-ene-1-carboximidic acid

C39H49N3O8S (719.324)


   

n-{1-[({6,18,24,28-tetrahydroxy-16-methoxy-5,7-dimethyl-22-thia-19,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),4,10,12,14,18,20(28),21(26),24-nonaen-8-yl}oxy)carbonyl]cyclopropyl}cyclohex-1-ene-1-carboximidic acid

n-{1-[({6,18,24,28-tetrahydroxy-16-methoxy-5,7-dimethyl-22-thia-19,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),4,10,12,14,18,20(28),21(26),24-nonaen-8-yl}oxy)carbonyl]cyclopropyl}cyclohex-1-ene-1-carboximidic acid

C39H49N3O8S (719.324)


   

n-[1-({[(8z,10z,16z)-3,15,24,28-tetrahydroxy-5-methoxy-14,16-dimethyl-22-thia-2,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),2,6,8,10,16,20(28),21(26),24-nonaen-13-yl]oxy}carbonyl)cyclopropyl]cyclohex-1-ene-1-carboximidic acid

n-[1-({[(8z,10z,16z)-3,15,24,28-tetrahydroxy-5-methoxy-14,16-dimethyl-22-thia-2,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),2,6,8,10,16,20(28),21(26),24-nonaen-13-yl]oxy}carbonyl)cyclopropyl]cyclohex-1-ene-1-carboximidic acid

C39H49N3O8S (719.324)


   

n-[1-({[(4z,10z,12z)-6,18,24,28-tetrahydroxy-16-methoxy-5,7-dimethyl-22-thia-19,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),4,10,12,14,18,20(28),21(26),24-nonaen-8-yl]oxy}carbonyl)cyclopropyl]cyclohex-1-ene-1-carboximidic acid

n-[1-({[(4z,10z,12z)-6,18,24,28-tetrahydroxy-16-methoxy-5,7-dimethyl-22-thia-19,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),4,10,12,14,18,20(28),21(26),24-nonaen-8-yl]oxy}carbonyl)cyclopropyl]cyclohex-1-ene-1-carboximidic acid

C39H49N3O8S (719.324)